Product
HH-003(20mg/kg)
1 clinical trial
1 indication
Indication
Hepatitis Delta Virus InfectionClinical trial
A Multicenter, Randomized, Controlled, Open-label Phase IIb Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus InfectionStatus: Recruiting, Estimated PCD: 2024-06-30